Urinary oestrogen excretion in benign prostatic hyperplasia and prostatic cancer.
Urinary oestrogen excretion was measured in 20 healthy middle-aged men (controls), in 30 patients with benign prostatic hyperplasia (BPH) and in 32 prostatic cancer (PC) patients. The mean oestradiol (E2) excretion was significantly lower in the PC patients than in the controls and BPH patients. No other significant differences were found in oestrone (E1), oestriol (E3) and total oestrogen (E1 + E2 + E3) excretion between the 3 groups. The decreased E2 excretion in the PC patients is in accordance with our previous finding concerning significantly lower E2 plasma levels in PC patients. It seems possible that elderly men with lower endogenous oestrogen levels are at higher risk of developing cancer. On the other hand, the age-dependent increased oestrogen levels may play an aetiological role in BPH.
Rannikko
S
S
Second Department of Surgery, University Central Hospital, Helsinki, Finland.
Adlercreutz
H
H
Haapiainen
R
R
D000368:Aged; D000369:Aged, 80 and over; D004958:Estradiol / Q000652:urine; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000652:urine*; D004970:Estrone / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000652:urine*; D011471:Prostatic Neoplasms / Q000652:urine*
D004967:Estrogens; D004970:Estrone; D004958:Estradiol; D004964:Estriol